An open-label study of safety of Fuzeon [enfuvirtide] plus an antiretroviral therapy of patient's choice in patients who previously participated in studies of Fuzeon.
Phase of Trial: Phase III
Latest Information Update: 18 Nov 2010
At a glance
- Drugs Enfuvirtide (Primary)
- Indications HIV infections
- Focus Adverse reactions
- Sponsors Roche
- 23 Feb 2010 Status changed from active, no longer recruiting to completed as reported by Roche record.
- 06 Jun 2006 New trial record.